Clinical Trials Browser

Terminated × Has results × rovalpituzumab tesirine × Clear all

NCT03033511 2021-07-29

MERU

Phase 3 Terminated

748 enrolled 13 charts

Neoplasms, Small Cell Lung Carcinoma

NCT02709889 2020-10-19

Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors

Phase 1/2 Terminated

200 enrolled 21 charts

CNSDermatologic

Glioblastoma, Melanoma, Carcinoma, Medullary

NCT03026166 2020-07-17

A Study of Rovalpituzumab Tesirine Administered in Combination With Nivolumab and With or Without Ipilimumab for Adults With Extensive-Stage Small Cell Lung Cancer

Phase 1/2 Terminated

42 enrolled 15 charts

Neoplasms, Small Cell Lung Carcinoma